[Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension].
N Nagaya(National Cerebral and Cardiovascular Center), Kenji Kangawa(National Cerebral and Cardiovascular Center), Yoshiaki Okano(National Cerebral and Cardiovascular Center), Mikio Kakishita(National Cerebral and Cardiovascular Center), Töru Satoh, Toshio Nishikimi(Kyoto University), S Kyotani, K Miyatake, Nobuhiro Nakanishi, Masaaki Uematsu(National Cerebral and Cardiovascular Center), Kenji Fukushima, Fumio Sakamaki(Keio University)
PubMed
February 1, 2001
Cited by 29
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478
Increased plasma levels of adrenomedullin in patients with heart failure
|Journal of the American College of Cardiology|1995|307